On 30 June 2026, Transcenta-B (Transcenta) approved two equity incentives under its 2022 Share Incentive Scheme: a grant of 451,500 award shares to 136 employees and a separate grant of 22,500 share options to nine employees.
Key terms of the award-share grant • Size: 451,500 shares, representing about 0.10 % of issued share capital (excluding treasury shares). • Participants: 135 employees (421,500 shares) and Non-executive Director Dr Hansen Xu (30,000 shares). • Cost to grantees: Nil purchase price and nil consideration. • Vesting: One- to four-year schedule for employees; three-year schedule for Dr Xu. • Pricing reference: HK$1.18 per share, the closing price on the grant date. • Performance targets: None. • Clawback: Unvested shares may be forfeited upon death, disability, redundancy or termination for cause; retirement vests as scheduled unless otherwise decided by the scheme administrator.
Key terms of the option grant • Size: 22,500 options, convertible into the same number of shares, equal to roughly 0.005 % of issued share capital. • Exercise price: HK$1.18, set at the highest of the grant-date close (HK$1.18), the prior five-day average close (HK$1.15) and par value. • Vesting: Fully vest one year after grant; exercisable within ten years, but not earlier than 12 months from the grant date. • Performance targets: None. • Clawback: Unvested options forfeit upon death or permanent disability, subject to administrator discretion.
Regulatory compliance • The 30,000 award shares for Dr Hansen Xu were approved by the independent non-executive directors in line with Rule 17.04(1) of the Listing Rules; Dr Xu abstained from voting. • No individual participant exceeds the 1 % single-participant limit, and no related-entity participants or service providers are included. • No financial assistance was provided for share purchases.
Scheme capacity After these grants, 926,990 shares remain available under both the overall scheme mandate limit and the service-provider sub-limit.
Rationale Management states the incentives are designed to retain key talent, align employee interests with shareholders and reward contributions to the Group’s long-term growth.